20172018

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2018

Disruption of IFN-I signaling promotes HER2/Neu tumor progression and breast cancer stem cells

Castiello, L., Sestili, P., Schiavoni, G., Dattilo, R., Monque, D. M., Ciaffoni, F., Iezzi, M., Lamolinara, A., Sistigu, A., Moschella, F., Pacca, A. M., Macchia, D., Ferrantini, M., Zeuner, A., Biffoni, M., Proietti, E., Belardelli, F. & Aricò, E., 2018, In : Cancer immunology research. 6, 6, p. 658-670 13 p.

Research output: Contribution to journalArticle

Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide

Buccione, C., Fragale, A., Polverino, F., Ziccheddu, G., Aricò, E., Belardelli, F., Proietti, E., Battistini, A. & Moschella, F., Mar 1 2018, In : International Journal of Cancer. 142, 5, p. 976-987 12 p.

Research output: Contribution to journalArticle

2017

The added value of type I interferons to cytotoxic treatments of cancer

Bracci, L., Sistigu, A., Proietti, E. & Moschella, F., Aug 1 2017, In : Cytokine and Growth Factor Reviews. 36, p. 89-97 9 p.

Research output: Contribution to journalShort survey